For example, we do not know whether SARS-CoV-2 would attack the heart via ACE2 or not, currently, no data is available to address whether myocardial damage has any effect on clinical prognosis (if so, to what extent), especially after the exclusion of COVID-19 patients with preexisting cardiovascular disease 9, 13. This evidence concerns the gene ACE2 and COVID-19.